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Abstract: A review of results of bioactivity and reactivity examinations of marine 
sesquiterpene (hydro)quinones is presented. The article is focused mostly on friedo-
rearranged drimane structural types, isolated from sponges of the order Dictyoceratida. 
Examples of structural correlations are outlined. Available results on the mechanism of 
redox processes and examinations of chemo- and regioselectivity in addition reactions are 
presented and, where possible, analyzed in relation to established bioactivities. Most of 
the bioactivity examinations are concerned with antitumor activities and the mechanism 
thereof, such as DNA damage, arylation of nucleophiles, tubulin assembly inhibition, 
protein kinase inhibition, inhibition of the arachidonic cascade, etc. Perspectives on 
marine drug development are discussed with respect to biotechnological methods and 
synthesis. Examples of the recognition of validated core structures and synthesis of 
structurally simplified compounds retaining modes of activity are analyzed. 
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1. Introduction 
 
The wealth of the oceans, the origin, number, versatility and coexistence of species and their 
survival mechanisms are fundamental questions that have occupied the imagination of scientists for 
ages. However, practical problems, mostly notably the restricted accessibility of organisms, have 
delayed a systematic and concerted approach to the study of marine life. In recent times, the 
improvements in the engineering of diving equipment and collection tools have enabled access to 
numerous species from various environments in sufficient amounts to allow reliable taxonomic 
classifications and detailed examinations of chemical constituents. As the result of the concerted 
efforts of investigators from various life science specialities over the last few decades, marine 
organisms are constantly yielding inspiring ideas related to the variety of unusual chemical structures 
of their metabolites, biosynthesis and the wide spectrum of biological functions and properties. The 
current progress in understanding the evolutionary history of marine organisms and of the effects of 
environmental conditions on adaptability is providing more rational guidelines for their selection as 
potential sources of bioactive secondary metabolites. 
Among the species within the marine animal kingdom, sponges are the most primitive multicellular 
organisms. As typical filter-feeders, they capture and digest organic particles to produce metabolic 
energy. Being sessile organisms, devoid of any physical capability for defense and found in 
environmentally different areas, sponges needed to develop adaptive responses and specific means for 
self-protection [1,2]. Consequently, their chemical constituents, primarily their secondary metabolites 
and their origin, structure and function, have attracted the most attention regarding several aspects of 
marine chemistry.  
 
2. Quinones with a rearranged drimane skeleton from sponges of the order Dictyoceratida  
 
The identification of secondary metabolites, isolated from different species, and correlation of the 
obtained data at the level of a particular class or order are of special importance in taxonomic 
determinations. Structural types of isolated compounds are usually classified according to standard 
principles of organic chemistry.  
One of the most widespread groups of constituents found in sessile organisms including sponges, 
are terpenoid quinones and hydroquinones, continuously reviewed and updated [3-5]. Since their great 
structural diversity, differences in origin, biosynthetic pathways and biological activities require 
further divisions, in this report primarily one subgroup is considered, namely the quinoid compounds 
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formed by a mixed shikimate-mevalonate biogenesis, resulting in formation of a 4,9-friedodrimane 
rearranged bicyclic sesquiterpene skeleton attached to a (hydro)quinone moiety. A representative 
group of compounds: avarol (1) [6] and avarone (2) [6] from Dysidea avara, ilimaquinone (3) [7,8] 
from Petrosaspongia metachromia (previously named Hippospongia metachromia), 
isospongiaquinone (4) [9,10] from Stelospongia conulata, the nakijiquinones 5a-d [11] from Spongia 
sp., bolinaquinone (6) [12] from Dysidea sp., is presented in Figure 1 and their chemistry and 
biological effects analyzed in the sections that follow. 
From the taxonomic point of view, it is important to mention that these structurally related 
compounds 1-6 were isolated from sponges belonging to the order Dictyoceratida, collected in 
different areas. They possess a common structural feature comprising a trans-decalin system in the 
rearranged drimane skeleton. Structural variations are found in the double bond position and in the 
substitution pattern in the quinone ring. Although similar in structure and having identical 
configuration of all asymmetric centers, (except for C-8 in bolinaquinone) these compounds present a 
wide variety of biological effects. 
 
Figure 1. Hydroquinones and quinones with friedo-rearranged drimane skeleton. 
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3. Structure 
 
The general structure of the first rearranged drimane containing sesquiterpenes, namely avarol (1), 
avarone (2) and their derivatives, was established by standard analytical methods, chemical 
degradation [13-15] and later by stereocontrolled synthesis [16]. However, in some other cases, the 
assignment of absolute stereochemistry of asymmetric carbon atoms was not simple and was shown to 
be unreliable if based on correlations of circular dichroism (CD) measurements of low magnitude. For 
instance, the configuration of the carbon atoms at positions C-5,8,9 and 10 in ilimaquinone (3) was 
initially assigned as enantiomeric to those in avarol (1) [7]. The error was later corrected [8] by 
chemical degradation and correlation of the CD measurement data of the obtained products with those 
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of compounds with firmly established stereochemistry to show that sesquiterpenoids 1, 2 and 3 have 
the same absolute stereochemistry, i.e. 5S,8S,9R,10S. This finding was of great importance for the 
determination of the absolute stereochemistry of other structurally related quinones which often occur 
as co-metabolites. Along with the efforts to correlate the stereochemistry of drimane- and 4,9-friedo-
drimane sesquiterpene quinones by instrumental methods, it was also shown that through adequate 
reasoning and the use of simple chemical reactions, relevant conclusions can be reached concerning 
chirality, (i.e. absolute stereochemistry) at particular carbon atoms. In this respect, by an acid catalyzed 
rearrangement of ilimaquinone (3) and isospongiaquinone (4), and of 5-epi-ilimaquinone (7) and 5-
epi-isospongiaquinone (8) (and vice versa), it was confirmed that both pairs yield the same mixture of 
products, unambiguously connected to ilimaquinone (Scheme 1) [17]. 
Scheme 1 
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By the same approach, the correlation between avarol (1) and arenarol (9) was also established, so 
that it was possible to stereochemically define an assembly of related sponge metabolites [17], 
including some with an unrearranged drimane skeleton [18] (Scheme 2). 
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Scheme 2 
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It is interesting to note that in acid catalyzed reactions of both ilimaquinone and avarol, a reversal 
of a friedo-like rearrangement takes place; formation of the tricyclic product 12 by avarol alkylation at 
C-1 (Scheme 3) was suggested to occur by a 1,2-H shift [17], involving an a priori less stable 
carbocation intermediate 11.  
 
4. Biosynthesis 
 
The pathway of formation of 4,9-friedo-rearranged marine sesquiterpenoids, was first proposed for 
avarol (1) [6]. As can be seen in Scheme 4, the cyclization of farnesyl pyrophosphate (FPP) takes place 
by an initial electrophillic attack at the head position of FPP giving rise to a concerted process leading 
to a bicyclic carbocationic intermediate from which the final products, i.e. drimane or 4,9-friedo-
drimane structural types are formed. Structurally, bolinaquinone (6) is an exception with respect to the 
position of the quinone moiety [12]; at present, no biosynthetic pathway has been proposed for this 
compound, although a 1,2 alkyl (instead of a hydride) shift to C-8 seems plausible. Recently, a few 
more C-8 substituted compounds were isolated from the Dysidea sp. sponges [19]. 
 
Scheme 4 
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5. Reactivity  
 
The chemistry of simple quinones and hydroquinones has been extensively studied and is well 
documented [20-22]. However, in specific and more complex systems, steric requirements and 
electronic distribution frequently affect reactivity in an unexpected fashion. 
Quinone reactivity studies generally rest on redox reactions and Michael addition/elimination 
reactions; in biological systems, both reactions require further subtle differentiations (Diels-Alder 
reactions not considered). From the physiological point of view, it is important to notice that the two 
processes are competitive and that both might be therapeutically effective but at the same time could 
be the cause of pronounced and non-selective cell toxicity. 
 
i) Redox reactivity  
 
Regarding the mechanism of the quinone/hydroquinone redox processes which lead to non-bonding 
transformations of the substrate, the proposals of a one-electron transfer reaction (I) vs. the hydride 
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transfer process (II) may be one of the issues determining toxicity and/or the type of biological 
activity.  
Q   [Q, NADH]   [Q·-, NADH·+]  [QH·, NAD·]  
      [QH-, NAD+]  QH- + NAD+      
I
 
           Q + NADH  QH- + NAD+      
II
 
However, the interpretation of the pathway of quinone redox cycling processes has been associated 
with a long-lasting controversy regarding the above mechanisms (reaction I vs. II). Various simple 
model systems, but also enzyme (or enzyme-like) models, under differently designed experimental 
conditions, offered mostly indirect evidence regarding the reaction pathway [23]. The frequently 
proposed successive one-electron transfer reaction (e-p-e) based on the well known redox potential 
depending ability of the quinone/hydroquinone (Q/QH2) couple to reversibly form radical 
intermediates by chemical activation processes led to a quite conceivable interpretation that these 
intermediates can affect cellular components either directly, or indirectly, by producing toxic oxygen 
radicals responsible for cell damage [24-26] (Scheme 5). 
 
Scheme 5 
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On the other hand, the proposal that the one-step two-electron transfer by the reduced form of 
nicotinamide adenine dinucleotide (NADH) or its derivatives, equivalent to a hydride shift (reaction 
II), takes place in an important biological model reaction, such as the reduction of carbonyl 
compounds, including quinones, implies an essentially different mechanism, affecting also biological 
effects. References to both opposing views are presented in several stimulating publications but 
differences in interpretation still persist [27-35].  
 
ii) Addition reactions 
 
Quinone addition-elimination processes greatly depend on the charge distribution within this 
conjugated system, influenced by reaction conditions, substituent effects, steric requirements and non-
bonding interactions between the quinone, nucleophile and the medium. For instance, in hydroxy-
substituted quinones, polarization can lead even to zwitterionic structures, i.e. to synthetically useful 
ylide formation [36]. Reaction conditions such as solvent changes, temperature etc., were examined in 
a study of nucleophilic substitutions of methoxy-alkyl-p-benzoquinones related to a regioselective 
quinone-enamine coupling process for the formation of the nat-mitomycin backbone: a solvent 
induced reversal of regioselectivity was established by changing polar protic to polar aprotic solvents 
[37]. The regioselectivity of addition reactions of thiols, amines, methanol and hydrogen chloride to 
avarone (2) was investigated and it was shown to be influenced by the electrophilicity of position 4’ in 
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unprotonated avarone, the increased electrophilicity of position 3’ in acidic medium (Figure 2), and by 
the acidity of the intermediate hydroquinones [38]. Substitution in position 6’ was never observed.  
 
Figure 2. Activation of position 3’ in avarone by protonation. 
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Our further efforts to synthesize on a larger scale quinones with a different skeleton and to examine 
their reactivity[39-41], resulted in preparation of steroidal ring A p-quinone 13 and derivatives in good 
yield (Scheme 6). 
Scheme 6 
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The process of regiospecific acid catalyzed methanol addition to 13 was also examined by 
conformational analysis (PM3, AM1, MNDO) of the parent quinone and of the possible protonated 
intermediates [42]. It was suggested that the geometry of the unsubstituted ring A p-quinone is 
characterized by deviations from planarity (Figure 3), while protonation flattens the ring, requiring 
twice the energy compared to p-benzoquinone [43]. The high regiospecificity of addition to C-2 was 
ascribed to differences in angle deformations in transition states.  
Figure 3. The PM3 optimized geometry of 13. 
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The effect of substituents on chemo- and regioselectivity in addition reactions was also clearly 
demonstrated in radical reactions. To secure efficiency in an enantioselective synthesis of 1, 2 and 3 
[44], a series of differently substituted quinones and their respective reactivity in photochemical 
radical decarboxylation reactions using thiopyridone derivatives [45] and quinone addition reactions 
on symmetrical and unsymmetrical quinones was examined. It was concluded that chemoselective 
addition takes place only on unsubstituted, conjugated double bonds, while regioselectivity of addition 
in quinones acting as radical traps is greatly influenced by the resonance effect of heteroatoms attached 
to the quinone ring; in some cases it reached a ratio of 15:1 or higher. A part of this unified approach 
to the synthesis of sesquiterpene quinones 1 and 2 is presented in Scheme 7.  
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6. Biological effects 
 
i) Antitumor activity  
 
Many marine sesquiterpenoid quinones and hydroquinones are of considerable interest with 
regards to their versatile biological activities; also, a particular (hydro)quinone may display multiple 
activities. Compounds of structural types combining a decalin-type terpene unit and a quinoid moiety 
isolated from marine organisms are often characterized by pronounced cytotoxic activities. Such 
compounds may have in vitro IC50 values towards cell lines in the micromolar range. Most of them are 
sesquiterpenoids, (usually with the drimane skeleton, e.g. puupehenone (14) from the sponge Hyrtios 
sp. [46,47], which also shows a potent antituberculosis activity [48]). Among those are also the ones 
with a 4,9-friedo-rearranged skeleton, such as ilimaquinone (3) [49], and a related amino derivative 15 
from the sponge Dactylospongia elegans [50], the nakijiquinones 5 [11] and especially avarone (2) and 
avarol (1), with strong ED50 activities of 0.62 µM and 0.93 µM, respectively, for mouse lymphoma 
cells [51,52]. Also, strong activity was evidenced for several hydroxy and acetoxy derivatives 16-18 of 
avarol and avarone, isolated from the marine sponge Dysidea cinerea [53] (Figure 4). It is interesting 
that arenarol (9), structurally similar to avarol but with a cis-decalin system, has approximately 20 
times lower activity towards P388 lymphotic leukemia cells than avarol [54,55]. On the other hand, in 
this system, 3,4-dihydroavarol has only a slightly weaker activity than avarol [52]. The in vitro 
specificity of avarol, avarone and their derivatives toward leukemia cell lines, higher for an order of 
magnitude than against any other tumor cell lines (e.g. 4’-isobutylthioavarone (19) has GI50 against 
CCRF-CEM leukemia cells 1.3 µM, compared to an average GI50 of 11 µM against all cell lines in the 
NCI panel) makes them good lead compounds in search for new therapeutic agents. The 
avarol/avarone redox couple also showed antileukemic activity in vivo, with a therapeutic index of 
11.7 for avarone and 4.5 for avarol [52]. Of several avarone derivatives synthesized by nucleophilic 
addition of O-, N-, and S-nucleophiles, only a few had a higher antileukemic activity to certain cell 
lines in vitro than the parent compound, e.g. 3’-methoxyavarone (20) [15, 42] and 3’-alkylamino 
avarone derivatives [56]. Avarol and avarone have manifold other biological activities: antiviral, 
antiinflammatory (see below), moderate antibacterial against Gram-positive strains and antifungal 
[57].  
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Among similar compounds some are diterpenoids, such as the ester 21, related to atomaric acid, 
isolated from the brown alga Stypopodium zonale [58], with IC50 values against human lung and colon 
carcinoma cell lines of 2.5 µM or less. 
The presence of a bicyclic system is not a prerequisite for a significant cytotoxic activity. 
Metachromins A (22), and B (23), hypochromin A diacetate (24) and metachromin B monoacetate (25) 
(Figure 5) exhibit potent cytotoxicities against human colon and nasopharyngeal tumor cells with IC50 
values of less than 1 µM [59]. Another example is the moderately cytotoxic naphthoquinone 
sesquiterpene neomarinone (26) produced by a marine actinomycete [60]. A tricyclic meroterpenoid 
quinine, strongylophorine (27), from the marine sponge Petrosia corticata, shows a significant activity 
in an anti-invasion assay [61]. Since tissue invasion via cell migration is a common process in 
angiogenesis and metastasis, the structure of this substance might also be helpful in the development of 
new anticancer drugs. 
Figure 5 
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Several structure activity relationships (SAR) studies were performed with the aim of improving the 
activity of compounds based on natural product structural models. One possible approach is the 
synthesis of unnatural enantiomers to improve the understanding of SAR requirements. Some of these 
analogues, such as enantiomers 28 and 29 of isozonarol and isozonarone, respectively, showed 
antitumor activity (IC50) in a micromolar range or less [62], i.e. higher than the corresponding natural 
products (Figure 6). 
Figure 6 
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An alternative approach was made by changing the isoprenoid moiety. In one study, monoterpene 
models 30a and 30b of puupehedione (31a) and puupehediol (31b), respectively, were synthesized 
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(Figure 7). Both compounds were active against tumor cells, the catechol compound having similar 
activity to the natural product, and the o-quinone having 4 times higher activity than the corresponding 
natural product (IC50 less than 1 µM) [63].  
Figure 7 
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In another biomimetic study, a new series of diterpenyl quinones and hydroquinones were prepared 
by Diels-Alder reactions between three labdanic diterpenoids and p-benzoquinone or 1,4-naphtho-
quinone. A representative example is compound 32 (Figure 8). Several of the obtained compounds 
showed IC50 values under the micromolar level, and an important selectivity toward renal cancer lines, 
identifying these compounds as a very promising group of antineoplastics. The structure of the 
compound 32 could be partially superimposed on the crystal structure of avarol, which allows 
speculation that these molecules might interact at the same site and in a similar molecular orientation 
[55]. 
Figure 8 
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 Some of the earlier mentioned steroidal ring A p-quinones [39-42] and related structural types show 
an expected anti-ovarian tumor activity since they are derived from estrogens (to be published). 
 
ii) Mechanisms of cytotoxic activity 
 
As mentioned, some type of biological activity was recorded for practically all of the 
sesquiterepene quinones with a rearranged drimane skeleton. In advanced approaches, additional 
evidence shedding more light on the likely mechanism of action was obtained. However, it is obvious 
that a rational design of drugs requires thorough understanding of the reactivity of functional groups, 
as parts of an envisaged pharmacophore, in chemically different environments.  
Cytotoxicity of friedo-rearranged sesquiterpenoid quinones is well documented but differences in 
experimental techniques, types of cells and targeted components etc. impede correlations leading to 
conclusions. Also, chemical reactivity examinations, especially those allowing extrapolation of 
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obtained data to the mechanism of action of particular compounds in biological systems, are usually 
lacking.  
 
General mechanisms 
 
In most relevant publications, quinone/hydroquinone cytotoxicity is usually attributed to two 
processes [26,64]:  
1) redox cycling of quinones, resulting in generation of reactive oxygen species which can damage 
biomolecules, and inhibition of the mitochondrial electron transport and/or of oxidative 
phosphorylation;  
2) electrophilic arylation of critical cellular nucleophiles, either by quinones or quinone methides 
formed after bioreductive activation of quinones [65]. 
To identify the principal mechanism is difficult for quinones showing various chemical reactivities. 
Both redox cycling and arylation of nucleophiles can result in oxidative stress and cell killing. One-
electron reduction of quinones to the corresponding semiquinone radicals is catalyzed by a number of 
NAD(P)H-oxidoreductases, including those associated to the mitochondrial electron-transport chain 
and the cytochrome P450 system of the endoplasmic reticulum [64], while two-electron reduction to 
hydroquinones is catalyzed by DT-diaphorase [66]. 
The above reactions were examined in other model systems in relatively close connection to 
quinone reactivity in biological systems. With simple naphthoquinones, it was found that NADPH-
cytochrome P-450 reductase catalyzes the reduction by initial one-electron transfer to form 
semiquinone anion-radicals which react with molecular oxygen to yield superoxide anion-radicals 
[65]. With DT-diaphorase, however, naphthoquinones are reduced to hydroquinones which can 
subsequently be autooxidized to semiquinones. By investigating the mechanism of acid catalyzed 
reduction of quinones by acridine (as a model for NADH), it was found that a hydride shift is clearly 
implicated [35]. Contrary to this finding, in a recent work [67], it was shown by electron paramagnetic 
resonance (EPR) that 9,10-phenanthrenequinone reduction takes place by a one-electron transfer 
process catalyzed by an NADPH-dependent quinone oxidoreductase. The same conclusion was 
reached by following the redox process of some naturally occurring quinones, also by EPR [68]. It 
must be mentioned that in most of the attempts to clarify the mechanism, experiments were carried out 
under conditions which could hardly be adopted as a proof for the course of events in a biological 
system. 
An appropriate general opinion, encompassing the proposed alternative mechanisms, was 
epitomized in a summary stating that the well known mitochondrial disfunction resulting in 
cytotoxicity may take place by any of the proposed mechanisms, including addition/elimination, 
depending primarily on the chemical structure and reactivity of the individual quinine [64]. 
When considering biochemical behaviour of quinone/hydroquinone couples, it has to be taken into 
account that hydroquinones are planar while quinones can adopt, with low energy requirements, 
various degrees of non-planarity [43], depending on the structure of quinone and the stereochemistry 
of enzyme-substrate interactions.  
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DNA damage 
 
The chemical reactivity in relation to the mechanism of bioactivity of avarol and avarone has been 
examined earlier and more systematically than that of other rearranged drimane-containing 
(hydro)quinones [69]. It was recognized that this quinone-hydroquinone couple undergoes redox 
interconversion so that in any biological assay the (time and pH dependant) presence of both 
compounds in some ratio should be taken into account.  
DNA damage was found to be one of principal causes of avarol/avarone cytotoxicity [70]. It was 
shown that avarol produces a significant DNA damage, primarily single-strand breaks, most probably 
indirectly by generating oxygen radicals. The effect is partly reversible, since the repair mechanisms 
are not affected. Participation of reactive hydroxyl radicals in DNA damage caused by avarol was 
established by experiments showing that tryptophan, a potent scavenger for hydroxyl radicals, inhibits 
the formation of strand breaks by cytotoxic concentrations of avarol in Friend erythroleukemia cells 
(FLC) [71], and by the study of effects of iron(II), and/or corresponding complexing agents on the 
amount of DNA damage induced by avarol in FLC [72].  
The importance of effects of oxygen radicals in the antileukemic activity of avarol and its 
specificity to leukemia cells is confirmed by a good correlation between the activities of the protective 
enzyme superoxide dismutase (SOD) in various cell lines and their sensitivities to avarol. Tumor 
tissues with the lowest levels of SOD were found to be the most susceptible to avarol [70]. There is 
also evidence that avarol and avarone inhibit the cytoplasmatic Cu/Zn-SOD, as well as the SOD in 
intact L5178y mouse lymphoma cell system [73,74], potentiating effects of oxygen radicals. Covalent 
binding of avarol to DNA was not observed [70].  
The formation of avarol semiquinone anion radicals was confirmed by electrochemical methods 
[75,76] and by EPR spectroscopy of products of air-oxidation of avarol and methanol reduction of 
avarone [77]. Still, we believed that evidence of semiquinone radical formation in biochemical 
reactions was insufficient. It seemed that the investigation of a relevant redox process such as the 
reaction of naturally occuring quinones with NAD(P)H models under conditions aimed to mimic those 
in biological systems, might be an adequate reaction although earlier examinations led to 
contradictiory conclusions (see above, [27-35]).  
Therefore, in our initial investigations, in analogy with earlier published studies, relative rates of 
oxidation of NADH model compound, 1-benzyl-1,4-dihydronicotinamide (BNAH) by quinones 2, 20, 
33-38 in anhydrous acetonitrile, in presence of various concentrations of magnesium perchlorate, and 
the respective cyclic voltammetric cathodic half-peak potentials (Ep/2) vs. saturated calomel electrode 
(SCE) [78] were correlated (Table 1). The relative rates follow the order of the respective half-peak 
potentials, with this tendency becoming more apparent in presence of Mg2+ ions. The interpretation of 
this trend rests on positive shifts of redox potentials E0 (Q/Q.-) as the consequence of the formation of 
the semiquinone-magnesium complex. The same trend in relative rates was observed in ethanol-water 
solutions, with Mg2+ effects being less pronounced because of the lower stability of the intermediate 
complex in presence of protons. 
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Table 1.  Relative rate constants (krel) of BNAH oxidation by quinones 2, 20, 33-38 
in anhydrous acetonitrile in the presence of various concentrations of 
magnesium perchlorate, [Mg2+], and the respective cyclic voltammetric 
cathodic half-peak potentials (Ep/2) vs. SCE. 
 
Compound 
krel 
[Mg2+]/mol dm-3 
Ep/2, V 
[Mg2+]/mol dm-3 
 0 1.0×10-2 1.0×10-1 0 1.0×10-2 
2 1.4 5.1 5.4 -0.56 -0.23 
20 1.6 5.0 5.3 -0.62 -0.34 
33 4.2 8.9 9.0 -0.43 -0.20 
34 5.9 11.8 14.3 -0.56 -0.36 
35 2.4 5.6 6.4 -0.58 -0.22 
36 2.3 5.9 6.5 -0.57 -0.34 
37 3.9 4.6 5.0 -0.38 -0.20 
38 7.2 7.8 7.8 -0.18 – 
Figure 9 
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In order to mimic biological conditions and to improve the understanding of the nature of 
intermediates, the same reaction was examined in presence of different concentrations of cationic, 
anionic and neutral surfactants (Table 2). The results clearly show that in presence of cationic micelles 
(cetyltrimethylammonium bromide, CTAB), depending on concentrations up to critical micellar 
concentration (CMC, 1.5×10 –3M), a rate increase for compounds 2, 20, 33, 34 (Figure 9) was 
recorded, while in presence of anionic micelles (sodium dodecyl sulfate, SDS) a slight rate decrease 
takes place; in neutral micelles (Tween), essentially no change in rate, relative to those in EtOH/water, 
was noticed. Based on these results and supported by the established stability of the quinone radical 
anion/CTA+ complex [79] with a stability constant of 1.4x10-2 at pH 8.1, the following stepwise 
electron transfer reaction pathway, involving quinone anion radical formation, is proposed: 
Q + BNAH          [Q  , BNAH   ]           [Q  , CTA+]  +  BNAH
CTA+
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Table 2. Relative rate constants (krel) of BNAH oxidation by quinones 2, 21, 33-38 in ethanol/water 
(3:2), pH 7, in the presence of various surfactants (1.5×10-3 mol dm-3) and magnesium perchlorate. 
 
krel Surfactant [Mg2+] 
(mol dm-3) 2a 20 33 34 35 36 37 38 
CTAB 0 3.1* 3.1 6.0 9.2 1.9 2.8 4.1 7.9 
CTAB 1.0×10-2 5.2§ 5.0 7.1 13.8 2.7 3.5 4.4 7.9 
CTAB 1.0×10-1 5.2 5.2 7.0 14.0 3.0 3.5 4.6 8.1 
SDS 0 1.0†b 1.4 2.5 4.8 1.9 2.0 2.9 6.6 
SDS 1.0×10-2 1.1‡ 1.6 2.6 5.0 2.1 2.1 3.1 6.6 
SDS 1.0×10-1 1.1 1.7 2.7 5.1 2.1 2.2 3.1 6.7 
TWEEN 80 0 1.3 2.4 4.1 4.9 2.1 2.7 4.2 6.1 
TWEEN 80 1.0×10-2 1.9 3.4 4.6 5.1 2.4 2.8 4.4 6.4 
TWEEN 80 1.0×10-1 2.1 4.0 4.6 5.2 2.8 3.4 4.5 6.7 
(a) Cyclic voltammetric cathodic half-peak potentials (in V vs. SCE) were as follows: -
0.13(*), -0.04(§), -0.14(†), -0.08(‡); (b) Reference rate. 
 
The lower reactivity of quinones 35-38 can be explained by the less lipophilic character of these 
compounds (less solubilized in the micellar pseudophase). In another study the e-p-e mechanism was 
supported by the fact that long-chain N-alkyl-1,4-dihydronicotinamides, compared to less lipophilic 
short-chain analogues, show a significant increase in the reaction rates of avarone reduction in protic 
solvents. This effect is a consequence of the stabilization of the intermediate radical-ion pair by 
automicellization [80]. A more precise description of the nature of the intermediate in avarone 
reduction was obtained by cyclic and rotating disc electrode voltammetry in micellar systems [79]. In 
presence of the cationic micellar agent CTAB, two well-defined peaks in avarone reduction can be 
observed in cyclic voltammograms, confirming one-electron reduction, whereby the intermediate 
avarone radical-anion was stabilized by the cationic micellar medium. The relevance of 
electrochemical data to understanding of biological avarone reductions could be seen from similar 
dependence of one-electron reduction potential and the rate constant for the reaction between avarone 
and BNAH on concentration of CTAB (Figure 10).  
 
Figure 10. (a) Plot of Ep vs. log cCTAB for 1 mM avarone at pH 9,1 (o); (b) Plot of log k 
vs. log cCTAB at pH 9.1 for the reaction of BNAH and avarone (●). 
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In accordance with this mechanism, derivatives with more negative redox potential generally tend 
to have a higher cytotoxicity. It is interesting that DNA damage effected by oxygen radicals was 
shown for synthetic phenolic antioxidant tert-butylhydroquinone [81], which can be considered as a 
crude model of avarol.  
DNA damage was suggested to be one mode of cytotoxicity for mamanuthaquinone (39, Figure 11), 
a metabolite of the sponge Fasciospongia sp. showing activity against human colon tumor cells [82]. 
Figure 11 
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Arylation of nucleophiles 
 
Avarone (2) was found to modify sulfhydryl groups both in glutathione and in bovine serum 
albumin, causing depletion of soluble and protein thiols both in vitro and in vivo [83,84]. Modification 
of sulfhydryls can be related to oxidative stress and/or enzyme inhibition.  
In our studies [85,86] it was found by SDS polyacrylamide gel electrophoresis and 
isoelectrofocusing that β-lactoglobulin is modified via lysine amino groups, both by avarone and the 
synthetic steroidal quinone 13 (see Scheme 6 above) and their derivatives. The hydrolytic enzyme 
lysozyme and the hydrolytic enzyme hexokinase are also modified and inactivated by forementioned 
compounds (to be published). The derivative 3’4’-ethylenedithioavarone (40) was shown not to 
modify the proteins, since only the least reactive 6’-position of the quinone nucleus is available for 
addition. The derivative 40 has a much lower antitumor activity than avarone and its monosubstituted 
derivatives, so it becomes obvious that the nucleophilic addition is also a relevant mechanism of 
cytotoxicity of avarone and its derivatives (to be published). It must be pointed out that the derivative 
40 has the redox potential similar to those of protein-modifying monoalkylthio derivatives, implying 
that lower activity is not always a consequence of the difference in redox properties.  
Figure 12 
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Other disubstituted avarone derivatives, such as 41 [14], and 42 [53] are also much less active than 
the similar monosubstituted compounds (Figure 12). The notable exception are the nakijiquinones, 
natural derivatives of avarone, which act as tyrosine kinase inhibitors (see below).  
A compound whose structure differs from typical natural sesquiterpene quinones in that it has a 
quinone-methide system is puupehenone (14), and it was suggested that it interacts with DNA through 
addition to the quinone methide [87]. 
 
Tubulin assembly inhibition 
 
Avarol (1) is an antimitotic agent, arresting cells during mitosis, and preventing karyokinesis 
without changing the appearance of the metaphase chromosomes [88]. Tubulin is crucial to cell 
division by depolymerization/repolymerization of microtubules to form a mitotic spindle. Prevention 
of this cycle is important in cancer chemotherapy. Avarol strongly inhibits polymerization of brain 
microtubule protein in vitro, as shown by viscosimetric analyses and electron microscopic studies [88]. 
Its effects are similar to those of colchicine and podophyllotoxin, although there is a significant 
difference [89] in that avarol inhibits protofilament elongation, rather than lateral association of tubulin 
during protofilament formation. At the same time, this mechanism differs from that of taxol, which 
stimulates the formation of microtubules by preventing the depolymerization process [90].  
 
Protein kinase inhibition 
 
Protein kinases, and in particular receptor tyrosine kinases (RTKs) have been identified as relevant 
molecular targets for treating cancer [91,92]. Several antitumor hydroquinones and quinones with a 
4,9-friedodrimane skeleton showed potent, and often selective, protein in vitro kinase inhibitory 
activity. For instance, ilimaquinone (3) inhibits tyrosine kinase by 87 % at a concentration 1 µg/mL 
[93], and isoarenarol (43, Figure 13) and arenarol 9 from Dysidea arenaria inhibit several medically 
relevant protein kinases, with IC50 as low as 4 µM [94]. Interestingly, avarol (1) and several 
derivatives of avarone (2) were inactive against pp60v-arc protein tyrosine kinase, with the only 
exception of the taurino derivative melemeleone B (44, Figure 13), which was moderately active (IC50 
= 28 µM) [95].  
Figure 13 
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A comprehensive study was carried out with nakijiquinones (5) [96], after the discovery that 
nakijiquinones have a selective inhibitory activity against Her-2/Neu (also called erb B-2) receptor 
tyrosine kinase [11]. The nakijiquinones are the only naturally occurring inhibitors of this important 
oncogene product, vastly overexpressed in about 30% of primary breast, ovary and gastric carcinomas. 
Fourteen nakijiquinones and some related compounds, such as isospongiaquinone (4) and 
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ilimaquinone were also investigated as possible inhibitors of several different receptor tyrosine kinases 
[96], but almost all tested compounds were found to be only poor inhibitors of the investigated kinases. 
However, the synthetic 2-epi-nakijiquinone (45, Figure 14) is a good and selective inhibitor of 
VEGFR2 (KDR) with an IC50 value of 21 µM at adenosine triphosphate (ATP) concentration of 25 
µM. Obviously, even minor stereochemical differences between agents might be an important 
determinant of the tyrosine kinase inhibiting potency. By molecular modelling studies probable 
interactions of the ligand with the ATP-binding domain of the kinase were identified. Inhibitors of the 
KDR receptor are very promising agents for cancer chemotherapy, since they prevent angiogenesis. 
Based on the structure of nakijiquinone C, a library of analogues was synthesized and investigated for 
inhibition of kinases with highly similar ATP-binding domains (see below). Using molecular 
modeling, studies in constructing homology models of some of the RTKs were also undertaken, with 
the aim to reveal sites in the kinase structure essential for the development of tailor-made new 
structural types for a more selective and efficient inhibition of different RTKs, chosen as crucial 
targets.  
Frondosin A (46, Figure 14), a hydroquinone with a novel skeleton, and several related compounds 
from the sponge Dysidea frondosa showed a strong inhibitory activity against protein kinase C-α, with 
IC50 as low as 1.8 µM [97].  
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The presented results do provide insights allowing reasonable speculations with respect to some of 
the mechanisms by which quinones exert antitumor activity. It is to be expected that advanced 
examinations aimed at specific targets, will provide new ideas and lead compounds for cancer therapy.  
 
iii) Antiviral activity 
 
Several naturally occurring sesquiterpene hydroquinones and quinones were found to inhibit 
various activities of HIV (human immunodeficiency virus) reverse transcriptases. Avarol (1) and 
avarone (2) were the subject of extensive studies, due to their ability to effectively inhibit HIV 
replication in vitro [98]. Unfortunately, clinical usefulness of the compounds could not be confirmed in 
AIDS patients. In a study, a series of avarone derivatives was tested in culture systems as antiviral 
agents, but none of them showed anti-HIV activity superior to that of the parent compounds [56]. 
However, most of them behaved as potent and selective inhibitors of polio virus (also a RNA virus) 
multiplication. Avarol and avarone and some other related natural products were the subject of 
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extensive studies. From the compounds tested, it appears that one of the necessary prerequisites for 
inhibition of HIV-1 reverse transcriptase activities is the presence of hydroxyl group at the 
hydroquinone or quinone ring, as shown by the structure of the most active compound 42 (Figure 12) 
[99]. The compounds inhibit indiscriminately the RNA-dependent and DNA-dependent DNA 
polymerase as well as the ribonuclease H activity of HIV-1 reverse transcriptase. Ilimaquinone (3) was 
also active, but it was found to inhibit only the ribonuclease H and not DNA polymerase activities 
[100]. It should be mentioned that ilimaquinone was found to inhibit the lyase activity of eukariotic 
DNA polymerase β [101]. This enzyme can repair damage after exposure to DNA-damaging agents, 
and inhibitors of this enzyme can potentiate cytotoxic activity and can be used as chemopotentiating 
agents in cancer treatment.  
Avarol was suggested to exert its anti-HIV activity through a mechanism not involving inhibition of 
reverse transcriptase activity, but affecting its biosynthesis [102]. A hydroxyl group bound to 
hydroquinone or quinone ring is not always necessary for inhibitory activity against reverse 
transcriptase. For instance, peyssonols A (47) and B (48) (Figure 15) from the Red Sea red alga 
Peyssonelia sp. are potent inhibitors of RNA-directed DNA synthesis activity of the reverse 
transcriptases of HIV-1 and HIV-2 [103], the DNA-dependent activity being less inhibited and RNAse 
H activity unaffected. Also, 2-hexaprenylhydroquinone (49, Figure 15) from the sponge Ircinia sp. 
was shown to be an inhibitor of retroviral reverse transcriptases from HIV-1, HIV-2 and murine 
leukemia virus, as well as of cellular DNA polymerases [104]. Its inhibition was attributed to the effect 
on nucleotidyl-transfer catalytic reaction. Marine natural products with anti-HIV activity have been 
recently extensively reviewed [105].  
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iv) Antiinflammatory activity 
 
Avarol (1) and some related compounds show antiinflammatory activity. Avarol  was found to be a 
moderate inhibitor of human recombinant synovial phospholipase A2 and cyclooxygenase and a good 
inhibitor of lipoxygenase [106,107]. Both avarol and, especially, avarone (2) inhibited the platelet 
aggregatory process [84]. Antiinflammatory effects of avarol were also ascribed to its behaviour as 
chain-breaking antioxidant of the arachidonate cascade, and/or as a scavenger of radicals. Of particular 
interest is the anti-psoriasis activity of avarol and some of its and avarone derivatives [108].  
The secretory phospholipase A2 (PLA2) is strongly inhibited by bolinaquinone (6), with a potency 
on the human synovial enzyme (group II) higher than that of manoalide [109]. Bolinaquinone also 
inhibits 5-lipoxygenase activity. These activities contribute to modulatory effect of this metabolite on 
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acute and chronic inflammatory processes. It was recognized that PLA2 is involved in a wide spectrum 
of pathophysiological conditions, including cancer [110].  
Puupehenone (14) showed a better activity to 12-human, 15-human and 15-soybean lipoxygenases 
than the well known redox inhibitor nordihydroguaiaretic acid [111]. It behaves as a redox inhibitor, 
reducing the iron site. Good inhibitory potency and notable selectivity were exhibited by the non-
reducing inhibitor dimethoxypuupehenol (50, Figure 16)  
Prenyl hydroquinones of the type 51 (Figure 16) isolated from the sponge Ircinia spinosula showed 
an antiinflammatory activity which was at least in part a consequence of phospholipase A2 inhibition 
[112]. 
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v) Golgi-disturbing activity 
 
Contrary to usual approach of modern pharmacology which deals with defined molecular targets, 
interfering with Golgi function is more complex and is recognized by blocking secretion, altering 
morphology by dispersing Golgi structural elements, loss of cisternal stacks or inhibition of vesicular 
transport, the molecular targets often being unknown [113]. 
Ilimaquinone (3) has the ability to disrupt the Golgi apparatus [114] into small vesicles blocking 
cellular secretion in a reversible manner. In a detailed study of several ilimaquinone analogs and 
derivatives (Figure 17), it was found that rearranged drimane quinones without substituents in the 
quinone moiety have a lower activity than ilimaquinone in the order ilimaquinone > arenarone (52) > 
isoavarone (53) > avarone (2). On the other hand, ilimaquinone derivatives 54 and 55 are more active. 
The effect was not directly connected to the antitumor activity, but it was suggested that it could have 
implications on antitrypanosomal activity of ilimaquinone [115].  
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The active derivative 55 with a tether binding ilimaquinone structure to a protected amino group 
was used for preparing affinity resins 56 (Figure 18) with the aim of identifying potential target for 
antisecretory activity [116]. Affinity chromatography experiments showed that ilimaquinone interacts 
with enzymes of the activated methyl cycle: S-adenosylmethionin synthetase, S-
adenosylhomocysteinase and methyl transferases. These results offer new opportunities for therapies 
of viral infections and atherothrombosis therapies considering the involvement of S-
adenosylhomocysteinase in these diseases.  
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7. Marine pharmacology: perspectives 
 
A great number of compounds with “promising biological activities” were isolated from marine 
sources, but not many were the subject of advanced biochemical investigation and only a few reached 
clinical evaluation. The reasons for a modest interest for marine organisms research by the 
pharmaceutical industry essentially rest on availability and regular, economically acceptable, supply of 
these “rich sources of new compounds”. Nevertheless, this discouraging attitude has not affected the 
search for new chemical components as general indicators of marine life processes contributing to the 
ecological and environmental awareness as the conditio sine qua non for the development of 
civilisation. Therefore, the use of some marine natural products to be used for practical purposes truely 
depends on surmounting concomitant limitations to secure sufficient amounts of organisms without 
disturbing the envionmental balance. Among the ways to solve this problem are biotechnological 
methods. Substantial progress was already made in biomass production of sponges based on the 
regenerative power of their undifferentiated cells [117,118]. Also, in spite of the difficulties of sponge 
cultivation in natural habitat, several small-scale experiments with different sponge species were 
relatively fruitful [119], while in a closed system, a high growth rate of Pseudosuberites andrews, 
using microalgae as food source, was achieved. The attempts to produce secondary metabolites by 
sponge cell cultures are still mostly unsuccessful. However, achievement in production of cell 
aggregates from single cell cultures of a sponge species Suberites domuncula, and preserving them in 
culture for 5 months without a food source, is very encouraging [120,121]. Another line of 
investigation, with a great metabolite production potential, are marine bacteria and fungi. To some 
extent, this approach is complicated by the facts that in many cases it is not clear whether an isolated 
metabolite originates from the host organism or the symbiotic bacteria and also the question whether 
the symbiont and/or the host, if separated, will retain the same metabolic production. As suggested in 
recent publications, there is an apparent need for better understanding of the host – microbe 
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interactions in an ecologically relevant context [122]. In the search for new actinomycetes from deep 
ocean muds (beyond 1500 m), it was established that even organisms living in extreme conditions, can 
be cultivated to produce medicinally valuable products as such or as lead compounds [123,124]. 
Obviously, current advances in bioprocessing methodology and (bio)technology, also relevant for the 
aforementioned efforts to improve supply, seem to be a feasible element in the strategy to ensure 
economically justified production of secondary metabolites. 
Organic synthesis, although a mainstay of the pharmaceutical industry, is not largely engaged in the 
production of marine natural products, even of those with an apparent pharmacological potential. The 
usual structural complexity, i.e. multistep procedures resulting in low overall yields, do not comply 
with the cost-benefit principle. Therefore, new reactions discovered and brilliant strategic principles 
developed in the total synthesis of natural products over the last years [125] are frequently applied in 
competitive production processes of other products, compatible with economic rules. Nevertheless, 
since great progress is being achieved in recognising the pharmacophore in a given bioactive natural 
product, new ideas based on core structures for the preparation of structurally simple drug candidates, 
are developing with increasing success. 
A very good example confirming the usefulness of this concept is an elaborated approach to the 
targeted design of a library of antitumor agents based on a "biologically validated" core structure of 
nakijiquinones [96,126,127] 5a-d (see above). Among the newly synthesized compounds, some were 
found to be pronounced inhibitors of receptor tyrosine kinases (RTKs), critically involved in 
angiogenesis. In order to establish main structural features of compounds affecting the activity of these 
enzymes, the same group extended the library to more than 70 nakijiquinone analogues which could be 
biologically evaluated. The first set of analogues was structurally closely related to the selected 
nakijiquinones, while the second contained compounds modified both in the terpene hydrophobic unit 
and the quinone ring. The working hypothesis was that the terpene part will occupy the hydrophobic 
pocket close to the binding site of ATP in the receptor, while the quinone ring was expected to interact 
with the hinge region of the RTKs. The method of choice was the solution-phase synthesis, guided by 
the modular composition of the natural product. Some of the components of the modular composition 
of the nakijiquinone library are outlined in Figure 19. In analogy with parent nakijiquinones, a series of 
different RTKs were chosen as crucial targets in the search for anticancer drug development.  
Figure 19. Examples of nakijiquinone library structural types. 
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The results obtained have shown that nearly 10% of the simple, easily available compounds in this 
library are inhibitors of RTKs, and four of them (57-60, Figure 20), of the Tie-2 receptor kinase. In 
parallel, molecular modeling studies in construction of homology models of different RTKs were also 
undertaken with the aim to reveal sites in the kinase structure essential for the development of more 
selective and efficient inhibitors of RTKs. As presented, even a change on a single chiral center results 
in pronounced activity differences of RTKs inhibitors.  
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Using such and similar approaches, in conjunction with molecular modeling of the receptor binding 
site, tailor made compounds with a more selective and powerful effect of inhibition of RTKs can be 
developed.  
Another illustrative general example of successful modification of biologically active compounds, 
structurally unrelated to sesqiterpene quinones, is the attempt to  simplify structures of bryostatin-1 
(61, Figure 21), a powerful antineoplastic macrolide from a marine bryozoan (128,129) and to 
establish SAR requirements [128,129] for preserving its exceptional pharmacological properties. 
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In a series of experiments, important discoveries and goals were achieved: a) the experimental data 
validate the design of the simplified pharmacological model structure; b) the newly developed 
analogues 62 and 63 (Figure 21) have in vitro and in vivo biological activities similar or higher than 
bryostatin and c) by practical total synthesis, the analogues are made available in sufficient amounts 
for clinical trials. In a similar approach [130] a series of designed analogues of laulimalide (64, Figure 
22) a powerful microtubule stabilizing agent, isolated from a marine sponge Cacospongia mycofijensis 
[131] were prepared. This 20-membered macrolyde is relatively unstable, under mildly acidic 
conditions being transformed to a substantially less active isomer. Some of the analogues of simplified 
structures, however, are stable and retain the antiproliferative activity against tumor cells. Subtle 
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differences in activities between analogues provide information for the design of the new and more 
effective therapeutic agents.  
Figure 22 
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The few of the results presented in this short “exercise in belief” and numerous other efforts over 
the last years confirm that pharmacophore recognition and organic synthesis and reaction mechanisms, 
in conjunction with structure-(re)activity relationship investigations, computer aided modeling, and 
organic synthesis including combinatorial methodologies, as well as biomass production, represent 
reliable assets in the process of discovery and production of important drugs. 
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